Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-19-257384
Filing Date
2019-09-27
Accepted
2019-09-27 16:24:38
Documents
79
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 6-K d747502d6k.htm 6-K 12499
2 EX-99.1 d747502dex991.htm EX-99.1 444839
9 GRAPHIC g747502dsp02.jpg GRAPHIC 2012
  Complete submission text file 0001193125-19-257384.txt   4121401

Data Files

Seq Description Document Type Size
3 XBRL INSTANCE DOCUMENT dbvt-20190630.xml EX-101.INS 891968
4 XBRL TAXONOMY EXTENSION SCHEMA dbvt-20190630.xsd EX-101.SCH 71424
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dbvt-20190630_cal.xml EX-101.CAL 88289
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbvt-20190630_def.xml EX-101.DEF 152048
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbvt-20190630_lab.xml EX-101.LAB 385903
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbvt-20190630_pre.xml EX-101.PRE 278596
Mailing Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120
Business Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36697 | Film No.: 191122366
SIC: 2836 Biological Products, (No Diagnostic Substances)